Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
29.36
+2.23 (8.22%)
At close: Dec 5, 2025, 4:00 PM EST
29.11
-0.25 (-0.85%)
After-hours: Dec 5, 2025, 7:56 PM EST
Terns Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -94.44 | -88.85 | -90.21 | -60.35 | -50.16 | -29.35 | |
| Depreciation & Amortization | 0.6 | 0.9 | 0.88 | 1.03 | 0.51 | 0.39 | |
| Loss (Gain) From Sale of Investments | -0.32 | -2.09 | -5.21 | 0.08 | 0.88 | 0.04 | |
| Stock-Based Compensation | 13.07 | 15.63 | 25.54 | 10.77 | 8.15 | 1.69 | |
| Other Operating Activities | 0.02 | 0.02 | 0.14 | 0.39 | 0.22 | -7.64 | |
| Change in Accounts Payable | 1.21 | -0.37 | 1.15 | -0.72 | 1.73 | -1.15 | |
| Change in Other Net Operating Assets | 2.18 | 4.75 | 0.33 | -0.32 | -3.15 | 6.21 | |
| Operating Cash Flow | -77.68 | -70.02 | -67.39 | -49.11 | -41.83 | -29.81 | |
| Capital Expenditures | - | -0.04 | -0.05 | -0.28 | -0.34 | -0.58 | |
| Investment in Securities | -42.39 | -12.37 | -37.94 | -22 | -119.36 | 7.28 | |
| Investing Cash Flow | -42.39 | -12.41 | -37.99 | -22.27 | -119.7 | 6.69 | |
| Short-Term Debt Issued | - | - | - | - | - | 16.88 | |
| Total Debt Issued | - | - | - | - | - | 16.88 | |
| Short-Term Debt Repaid | - | - | - | - | -12.88 | - | |
| Total Debt Repaid | - | - | - | - | -12.88 | - | |
| Net Debt Issued (Repaid) | - | - | - | - | -12.88 | 16.88 | |
| Issuance of Common Stock | 1.02 | 164.38 | 42.3 | 167.5 | 137.28 | 0.12 | |
| Other Financing Activities | -0.32 | -0.39 | -0.34 | -0.4 | 10 | -0.86 | |
| Financing Cash Flow | 0.7 | 164 | 41.95 | 167.1 | 134.39 | 85.52 | |
| Foreign Exchange Rate Adjustments | -0.07 | -0.06 | 0.12 | -0.18 | -0.03 | 0.08 | |
| Net Cash Flow | -119.44 | 81.51 | -63.31 | 95.54 | -27.16 | 62.48 | |
| Free Cash Flow | -77.68 | -70.06 | -67.44 | -49.38 | -42.17 | -30.39 | |
| Free Cash Flow Margin | - | - | - | - | -4216.70% | - | |
| Free Cash Flow Per Share | -0.85 | -0.88 | -0.95 | -1.37 | -1.86 | -106.58 | |
| Cash Income Tax Paid | 0.06 | 0.06 | 0.03 | 0 | 0.24 | 0.18 | |
| Levered Free Cash Flow | -51.27 | -43.26 | -36.12 | -27.38 | -10.9 | -30.09 | |
| Unlevered Free Cash Flow | -51.27 | -43.26 | -36.12 | -27.38 | -10.9 | -30.09 | |
| Change in Working Capital | 3.39 | 4.38 | 1.48 | -1.04 | -1.43 | 5.06 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.